Your browser doesn't support javascript.
loading
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.
Stuver, Robert; Mian, Agrima; Brown, Samantha; Devlin, Sean; Caimi, Paolo F; Chinapen, Stephanie; Dahi, Parastoo; Dean, Robert; Epstein-Peterson, Zachary D; Hill, Brian; Horwitz, Steven M; Lahoud, Oscar; Lin, Richard; Moskowitz, Alison J; Sauter, Craig; Shah, Gunjan; Winter, Alison; Jagadeesh, Deepa; Scordo, Michael.
Afiliação
  • Stuver R; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Mian A; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Brown S; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Devlin S; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Chinapen S; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Dahi P; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Dean R; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Epstein-Peterson ZD; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Hill B; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Horwitz SM; Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.
  • Lahoud O; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Lin R; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Moskowitz AJ; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Sauter C; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Shah G; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Winter A; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Jagadeesh D; Department of Medicine, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Scordo M; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Am J Hematol ; 99(6): 1180-1183, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38526002
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante Autólogo / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante Autólogo / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico / Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article